General form of registration statement for all companies including face-amount certificate companies

Going Concern and Management's Plans (Details Narrative) (10K)

v3.19.3.a.u2
Going Concern and Management's Plans (Details Narrative) (10K) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]                    
Accumulated deficit $ (10,207,567)           $ (10,207,567)   $ (7,624,134) $ (3,859,086)
Net Loss (863,524) $ (969,077) $ (750,832) $ (852,822) $ (1,206,255) $ (1,096,798) (2,583,433) $ (3,155,874) (3,765,047) (1,856,315)
Net cash used in operating activities             (1,236,659) $ (3,243,938) (3,707,914) (1,654,617)
Cash and cash equivalents $ 504,302           $ 504,302   1,740,961 $ 2,847,429
Clinical Trial Funding commitment from investor capital                 $ 1,800,000